243 related articles for article (PubMed ID: 28750419)
1. Pipamperone and delirium: a preliminary evaluation of its effectiveness in the management of delirium and its subtypes.
Boettger S; Knöpfel S; Schubert M; Garcia Nuñez D; Plichta MM; Klaghofer R; Jenewein J
Swiss Med Wkly; 2017; 147():w14471. PubMed ID: 28750419
[TBL] [Abstract][Full Text] [Related]
2. Atypical antipsychotics for the treatment of delirious elders.
Ozbolt LB; Paniagua MA; Kaiser RM
J Am Med Dir Assoc; 2008 Jan; 9(1):18-28. PubMed ID: 18187109
[TBL] [Abstract][Full Text] [Related]
3. Atypical antipsychotics versus haloperidol for treatment of delirium in acutely ill patients.
Rea RS; Battistone S; Fong JJ; Devlin JW
Pharmacotherapy; 2007 Apr; 27(4):588-94. PubMed ID: 17381385
[TBL] [Abstract][Full Text] [Related]
4. Haloperidol, risperidone, olanzapine and aripiprazole in the management of delirium: A comparison of efficacy, safety, and side effects.
Boettger S; Jenewein J; Breitbart W
Palliat Support Care; 2015 Aug; 13(4):1079-85. PubMed ID: 25191793
[TBL] [Abstract][Full Text] [Related]
5. Systematic review of antipsychotics for the treatment of hospital-associated delirium in medically or surgically ill patients.
Lacasse H; Perreault MM; Williamson DR
Ann Pharmacother; 2006 Nov; 40(11):1966-73. PubMed ID: 17047137
[TBL] [Abstract][Full Text] [Related]
6. Dose-dependent QTc interval prolongation under haloperidol and pipamperone in the management of delirium in a naturalistic setting.
Bohny P; Boettger S; Jenewein J
Front Psychiatry; 2023; 14():1257755. PubMed ID: 37854439
[TBL] [Abstract][Full Text] [Related]
7. Aripiprazole and haloperidol in the treatment of delirium.
Boettger S; Friedlander M; Breitbart W; Passik S
Aust N Z J Psychiatry; 2011 Jun; 45(6):477-82. PubMed ID: 21563866
[TBL] [Abstract][Full Text] [Related]
8. Is it possible to predict the clinical effects of neuroleptics from animal data? Part V: From haloperidol and pipamperone to risperidone.
Janssen PA; Awouters FH
Arzneimittelforschung; 1994 Mar; 44(3):269-77. PubMed ID: 7514873
[TBL] [Abstract][Full Text] [Related]
9. [Psychopharmalogical treatment of delirium in the elderly].
Drach LM
Med Monatsschr Pharm; 2014 Apr; 37(4):124-31; quiz 133-4. PubMed ID: 24779187
[TBL] [Abstract][Full Text] [Related]
10. Atypical antipsychotics in the treatment of delirium.
Wang HR; Woo YS; Bahk WM
Psychiatry Clin Neurosci; 2013 Jul; 67(5):323-31. PubMed ID: 23859663
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of risperidone in treating the hyperactive symptoms of delirium.
Liu CY; Juang YY; Liang HY; Lin NC; Yeh EK
Int Clin Psychopharmacol; 2004 May; 19(3):165-8. PubMed ID: 15107660
[TBL] [Abstract][Full Text] [Related]
12. Treating delirium in a general hospital: a descriptive study of prescribing patterns and outcomes.
Briskman I; Dubinski R; Barak Y
Int Psychogeriatr; 2010 Mar; 22(2):328-31. PubMed ID: 19785917
[TBL] [Abstract][Full Text] [Related]
13. Drug-related problems of antipsychotics in treating delirium among elderly patients: A real-world observational study.
Jenraumjit R; Somboon J; Chainan S; Chuenchom P; Wongpakaran N; Wongpakaran T
J Clin Pharm Ther; 2021 Oct; 46(5):1274-1280. PubMed ID: 33768628
[TBL] [Abstract][Full Text] [Related]
14. Long-term antipsychotic monotherapy for schizophrenia: disease burden and comparative outcomes for patients treated with olanzapine, quetiapine, risperidone, or haloperidol monotherapy in a pan-continental observational study.
Dossenbach M; Pecenak J; Szulc A; Irimia V; Anders M; Logozar-Perkovic D; Peciukaitiene D; Kotler M; Smulevich AB; West TM; Lowry AJ; Treuer T
J Clin Psychiatry; 2008 Dec; 69(12):1901-15. PubMed ID: 19012820
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of antipsychotic treatments for schizophrenia: interim 6-month analysis from a prospective observational study (IC-SOHO) comparing olanzapine, quetiapine, risperidone, and haloperidol.
Dossenbach M; Erol A; el Mahfoud Kessaci M; Shaheen MO; Sunbol MM; Boland J; Hodge A; O'Halloran RA; Bitter I;
J Clin Psychiatry; 2004 Mar; 65(3):312-21. PubMed ID: 15096069
[TBL] [Abstract][Full Text] [Related]
16. Treatment of delirium in supportive and palliative care.
Gagnon PR
Curr Opin Support Palliat Care; 2008 Mar; 2(1):60-6. PubMed ID: 18685397
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of atypical antipsychotics and choline esterase inhibitors in delirium: a review.
Grover S; Mattoo SK; Gupta N
Pharmacopsychiatry; 2011 Mar; 44(2):43-54. PubMed ID: 21394715
[TBL] [Abstract][Full Text] [Related]
18. Antipsychotics for the prevention and treatment of delirium in the intensive care unit: what is their role?
Devlin JW; Skrobik Y
Harv Rev Psychiatry; 2011; 19(2):59-67. PubMed ID: 21425934
[TBL] [Abstract][Full Text] [Related]
19. Comparison of haloperidol, non-haloperidol antipsychotics, and no pharmacotherapy for the management of delirium in an inpatient geriatric palliative care population.
Felton MA; Jarrett JB; Hoffmaster R; D'Amico FJ; Sakely H; Pruskowski J
J Pain Palliat Care Pharmacother; 2018; 32(2-3):141-148. PubMed ID: 31066639
[TBL] [Abstract][Full Text] [Related]
20. Antipsychotic Medication Use Among Older Adults Following Infection-Related Hospitalization.
Zhang Y; Wilkins JM; Bessette LG; York C; Wong V; Lin KJ
JAMA Netw Open; 2023 Feb; 6(2):e230063. PubMed ID: 36800180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
